| 827 |
DUNBAR CENTER |
515066 |
501 CALDWELL LANE |
DUNBAR |
WV |
25064 |
2017-03-22 |
154 |
D |
0 |
1 |
ZQ9211 |
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on resident interview, staff interview, and record review it was determined the facility failed to ensure two (2) of five (5) residents reviewed for unnecessary medications who received psychoactive medications were informed of the risks and benefits of psychoactive medications. Failure to provide residents and/or the legal representative information regarding psychoactive medications placed the residents at risk to not be fully informed about their care and potential alternate treatment options. Resident identifiers: #35 and #113. Facility census: 85. Findings include: a) Resident #35 Review of physician orders, on 03/21/17 at 10:15 a.m., revealed Resident #35 received the anti-psychotic medication, [MEDICATION NAME], and the anti-depressant medication, [MEDICATION NAME], daily since 09/09/16. On 03/21/17 at 10:25 a.m., review of the Minimum Data Set (MDS) with an Assessment Reference Date of 02/04/17 revealed the resident had moderately impaired cognitive skills. In an interview, on 03/21/17 at 11:35 a.m., Resident #35 was unable to state any of the medications she received nor what she took them for. Review of the resident's record, on 03/21/17 at 10:43 a.m., revealed a paper form entitled Psychotherapeutic Medication Administration Disclosure. The form included different classifications of psychoactive medications, their benefits, adverse reactions and special concerns for staff to select based on the resident's assessed care needs. While someone had circled the anti-psychotic medication [MEDICATION NAME], the form failed to identify the anti-depressant [MEDICATION NAME]. There were no signatures from the resident, the resident's representative, or facility staff, nor was there any indication verbal consent was obtained. There was no date on the form. In an interview, on 03/21/17 at 2:25 p.m., the Assistant Director of Nursing (ADON) #79 stated the hard copy of the Medication Administration Disclosure should be in the chart under the consent tab. She explained this was the facility's evidence the resident, or their representative, was informed about the use of the medication and it's risks and benefits. She reviewed the record, determined the only copy in it was blank, and stated she would check the thinned chart. She explained the admitting nurse, or the nurse who obtained the physician's orders [REDACTED]. At 2:35 p.m. ADON #79 returned and stated she reviewed the thinned chart and progress notes and was unable to locate any indication the resident or the resident's representative had been provided information regarding the use of, including risks and benefits, of the [MEDICAL CONDITION] medications. b) Resident #113 Review of physician orders, on 03/21/17 at 1:35 p.m., revealed Resident #113 received the anti-depressant [MEDICATION NAME], since 05/04/16. The orders also indicated the resident received the anti-psychotic medication [MEDICATION NAME], since 05/03/16, with a decrease in dose on 12/14/16 and an increase back to the original dose on 12/19/16. Review of the MDS with an ARD of 03/07/17, on 03/21/17 at 2:00 p.m., revealed the resident had severely impaired cognitive skills. In an interview, on 03/21/17 at 11:35 a.m., Resident #113 was unable to state any of the medications she received nor was she able to report what she took them for. Review of the resident's record, on 03/21/17 at 2:15 p.m., revealed a blank Psychotherapeutic Medication Administration Disclosure. The form had the resident's name written on it, but did not identify the classification of the medications, the benefits, adverse reactions or special concerns related to these medications. The form did not indicate whether the resident, or the resident's representative, had been provided this information. In an interview on 03/21/17 at 2:25 p.m., the ADON #79 reviewed the record and determined the only copy in it was blank. She stated, Well, she is a ward of the state, so. When asked if that meant the facility would not provide information about the medication to the resident's representative, she said, Well, no. She then stated she would check the resident's thinned record. At 2:35 p.m., she returned and stated she was unable to locate any indication the resident's representative had been provided information regarding the risks and benefits of the [MEDICAL CONDITION] medications. |
2020-09-01 |